| Recruiting | A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Glioblastoma Multiforme, Glioblastoma, Glioblastoma Multiforme, Adult | Phase 3 | 2024-11-08 |
| Recruiting | Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblast Glioblastoma Multiforme, Glioblastoma, Glioma | Phase 1 / Phase 2 | 2024-10-22 |
| Recruiting | A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patien Drug Resistant Epilepsy, Epilepsy, Seizures, Focal | Phase 1 / Phase 2 | 2024-09-13 |
| Recruiting | A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients Wi Drug Resistant Epilepsy, Epilepsy, Epilepsy, Temporal Lobe | N/A | 2024-09-01 |
| Completed | NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy Drug Resistant Epilepsy, Seizure, Seizure Disorder | N/A | 2021-10-07 |
| Completed | Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Recurrent Glioblastoma, High-Grade Glioma (WHO III-IV), Brain Tumor Recurrent | N/A | 2021-05-23 |
| Completed | Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients Glioblastoma Multiforme, Glioblastoma, Glioma | N/A | 2020-07-21 |
| Completed | Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy Drug Resistant Epilepsy, Epilepsy, Drug Resistant, Drug Refractory Epilepsy | N/A | 2019-06-17 |
| Completed | Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients Glioblastoma Multiforme, Brain Tumor, Glioblastoma | N/A | 2018-08-17 |